Literature DB >> 642707

Metabolic activation of procarbazine.

R J Weinkam, D A Shiba.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1978        PMID： 642707     DOI： 10.1016/0024-3205(78)90358-2

Source DB:  PubMed          Journal:  Life Sci        ISSN： 0024-3205            Impact factor:   5.037


× No keyword cloud information.
  13 in total

1.  Treatment of pediatric low-grade gliomas with a nitrosourea-based multiagent chemotherapy regimen.

Authors:  M D Prados; M S Edwards; J Rabbitt; K Lamborn; R L Davis; V A Levin
Journal:  J Neurooncol       Date:  1997-05       Impact factor: 4.130

Review 2.  Antineoplastic drugs in 1990. A review (Part II).

Authors:  D J Black; R B Livingston
Journal:  Drugs       Date:  1990-05       Impact factor: 9.546

Review 3.  Intestinal and liver toxicity of antineoplastic drugs.

Authors:  G B McDonald; N Tirumali
Journal:  West J Med       Date:  1984-02

4.  Granuloma pouch assay for mutagenicity testing.

Authors:  P Maier
Journal:  Arch Toxicol       Date:  1980-11       Impact factor: 5.153

5.  In vitro metabolism of 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin in human liver microsomes.

Authors:  Nan Zheng; Peng Zou; Shaomeng Wang; Duxin Sun
Journal:  Drug Metab Dispos       Date:  2010-12-22       Impact factor: 3.922

6.  Oncometabolite D-2-Hydroxyglutarate Inhibits ALKBH DNA Repair Enzymes and Sensitizes IDH Mutant Cells to Alkylating Agents.

Authors:  Pu Wang; Jing Wu; Shenghong Ma; Lei Zhang; Jun Yao; Katherine A Hoadley; Matthew D Wilkerson; Charles M Perou; Kun-Liang Guan; Dan Ye; Yue Xiong
Journal:  Cell Rep       Date:  2015-12-10       Impact factor: 9.423

7.  Determination of terephthalic acid isopropylamide in urine with a liquid chromatography/mass spectrometry (LC/MS) method.

Authors:  F Baumann; C Mauz-Körholz; D Clauss; S Borrmann; A Giannis; N Merkel; D Körholz; R Preiss
Journal:  J Clin Lab Anal       Date:  2008       Impact factor: 2.352

Review 8.  N-methyl antitumour agents. A distinct class of anticancer drugs?

Authors:  D Newell; A Gescher; S Harland; D Ross; C Rutty
Journal:  Cancer Chemother Pharmacol       Date:  1987       Impact factor: 3.333

9.  The in vivo cytotoxic activity of procarbazine and procarbazine metabolites against L1210 ascites leukemia cells in CDF1 mice and the effects of pretreatment with procarbazine, phenobarbital, diphenylhydantoin, and methylprednisolone upon in vivo procarbazine activity.

Authors:  D A Shiba; R J Weinkam
Journal:  Cancer Chemother Pharmacol       Date:  1983       Impact factor: 3.333

10.  DNA methylation in maternal, fetal and neonatal rat tissues following perinatal administration of procarbazine.

Authors:  O D Wiestler; P Kleihues; J M Rice; S Ivankovic
Journal:  J Cancer Res Clin Oncol       Date:  1984       Impact factor: 4.553
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.